Try our beta test site
1921 studies found for:    "Melanoma"
Show Display Options
Rank Status Study
21 Completed Intralesional PV-10 Chemoablation of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: PV-10 (rose bengal disodium, 10%)
22 Recruiting A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
Condition: Melanoma
Interventions: Drug: pembrolizumab + epacadostat;   Drug: pembrolizumab + placebo
23 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894)
24 Recruiting In Vivo Real-time Detection of Circulating Melanoma Cells
Condition: Melanoma
Intervention:
25 Terminated Interleukin-2 in Metastatic Melanoma
Condition: Melanoma Metastatic
Intervention: Drug: Interleukin-2
26 Unknown  A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: HyperAcute vaccine;   Drug: Pegylated Interferon-Alpha 2b
27 Withdrawn Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions
Condition: Melanoma
Interventions: Drug: MRX34;   Drug: Dexamethasone
28 Recruiting Treatment of Advanced Melanoma With MK-3475 and Peginterferon
Condition: Melanoma
Interventions: Drug: MK-3475;   Drug: Peginterferon alfa-2b
29 Recruiting BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: BGB324+pembrolizumab;   Drug: BGB324+dabrafenib and trametinib;   Drug: pembrolizumab;   Drug: dabrafenib and trametinib
30 Unknown  Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: ALS-357
31 Recruiting Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Condition: Melanoma
Interventions: Drug: Dabrafenib;   Drug: Trametinib;   Drug: Metformin
32 Unknown  A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma
Condition: Melanoma
Interventions: Drug: imatinib;   Drug: Interferon
33 Completed Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
Condition: Melanoma
Intervention: Drug: TKI258
34 Completed CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
Condition: Melanoma
Intervention: Drug: CY-503
35 Completed Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
Condition: Melanoma
Intervention:
36 Completed Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
Condition: Melanoma
Intervention: Biological: CYT004-MelQbG10
37 Recruiting A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Condition: Melanoma
Intervention: Drug: SHR6390
38 Completed Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
Condition: Melanoma
Intervention: Drug: P276-00
39 Terminated Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma
Condition: Melanoma
Intervention: Biological: naked DNA coding for protein AMEP
40 Terminated CP-461 in the Treatment of Patients With Advanced Melanoma
Condition: Malignant Melanoma
Intervention: Drug: CP-461

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.